Goal: Identify and translate innovative targets in immuno-oncology, ultimately enabling and advancing curative therapies for pediatric cancers and other catastrophic diseases.

Impact: This project will build a transformative model for translating data-driven discoveries in silico to preclinical validations at the bench and then to early clinical trials at the bedside by bridging immunology, systems biology, cancer biology, preclinical modeling, and clinical investigation.


Research Team